CRISPR/Cas9-mediated genome editing of <i>Schistosoma mansoni</i> acetylcholinesterase
Hong You(The University of Queensland), Donald P. McManus(QIMR Berghofer Medical Research Institute), Vanessa Rivera(Deakin University), Olga Kondrashova(QIMR Berghofer Medical Research Institute), Shiwanthi L. Ranasinghe(QIMR Berghofer Medical Research Institute), Malcolm K. Jones(The University of Queensland), Juliet D. French(The University of Queensland), Johannes U. Mayer(Malaghan Institute of Medical Research), Lambros T. Koufariotis(QIMR Berghofer Medical Research Institute), Xiaofeng Du(Agriculture and Food), Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Patrick Driguez(King Abdullah University of Science and Technology), Victoria H. Mann(George Washington University), Haran Sivakumaran(QIMR Berghofer Medical Research Institute), Wannaporn Ittiprasert(George Washington University), Nicola Waddell(QIMR Berghofer Medical Research Institute), Mary Duke(QIMR Berghofer Medical Research Institute), Paul J. Brindley(George Washington University)
Cited by 1
Related Papers
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Cholangiocarcinoma
|Nature Reviews Disease Primers|2021|830
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639
Genome-wide analysis of long noncoding RNA stability
|Genome Research|2012|592